Cargando…

A bibliometric study of the top 100 most-cited papers in neuroendocrine prostate cancer

BACKGROUND: This study used bibliometrics to define and analyze the characteristics of the first 100 most cited papers on the topic of neuroendocrine prostate cancer (NEPC). METHODS: We explored the Web of Science Core Collection database, and screened the top 100 most frequently cited articles and...

Descripción completa

Detalles Bibliográficos
Autores principales: Gan, Yu, He, Qiangrong, Li, Chao, Alsharafi, Bassam Lutf Mohammed, Zhou, Hengfeng, Long, Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027713/
https://www.ncbi.nlm.nih.gov/pubmed/36959803
http://dx.doi.org/10.3389/fonc.2023.1146515
_version_ 1784909766612484096
author Gan, Yu
He, Qiangrong
Li, Chao
Alsharafi, Bassam Lutf Mohammed
Zhou, Hengfeng
Long, Zhi
author_facet Gan, Yu
He, Qiangrong
Li, Chao
Alsharafi, Bassam Lutf Mohammed
Zhou, Hengfeng
Long, Zhi
author_sort Gan, Yu
collection PubMed
description BACKGROUND: This study used bibliometrics to define and analyze the characteristics of the first 100 most cited papers on the topic of neuroendocrine prostate cancer (NEPC). METHODS: We explored the Web of Science Core Collection database, and screened the top 100 most frequently cited articles and reviews with the title NEPC or small cell prostate cancer (SCPC). We conducted bibliometrics research on the screening results to identify the most influential journals and authors in the field of NEPC. RESULTS: The first 100 most cited papers have been cited a total of 14,795 times, from 73 to 833 times (mean ± standard deviation, 147.95 ± 101.68). All top 100 most cited papers were published from 1984 to 2019, and the total number of citations for papers published in 2016 was significantly higher than that for papers published in other years. The journal with the largest number of published papers is “Prostate” (n=8). “Neuroendocrine differentiation” has become the most frequently used author keyword. “Oncology” is the most popular topic in the field of NEPC. CONCLUSION: We analyzed the first 100 most cited papers in the NEPC field by collecting detailed information, which provide guiding opinions for finding the most influential journals and authors in NEPC-related fields. We hope to help researchers and readers in this field improve their understanding of NEPC research trends and provide ideas for future research from a unique perspective.
format Online
Article
Text
id pubmed-10027713
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100277132023-03-22 A bibliometric study of the top 100 most-cited papers in neuroendocrine prostate cancer Gan, Yu He, Qiangrong Li, Chao Alsharafi, Bassam Lutf Mohammed Zhou, Hengfeng Long, Zhi Front Oncol Oncology BACKGROUND: This study used bibliometrics to define and analyze the characteristics of the first 100 most cited papers on the topic of neuroendocrine prostate cancer (NEPC). METHODS: We explored the Web of Science Core Collection database, and screened the top 100 most frequently cited articles and reviews with the title NEPC or small cell prostate cancer (SCPC). We conducted bibliometrics research on the screening results to identify the most influential journals and authors in the field of NEPC. RESULTS: The first 100 most cited papers have been cited a total of 14,795 times, from 73 to 833 times (mean ± standard deviation, 147.95 ± 101.68). All top 100 most cited papers were published from 1984 to 2019, and the total number of citations for papers published in 2016 was significantly higher than that for papers published in other years. The journal with the largest number of published papers is “Prostate” (n=8). “Neuroendocrine differentiation” has become the most frequently used author keyword. “Oncology” is the most popular topic in the field of NEPC. CONCLUSION: We analyzed the first 100 most cited papers in the NEPC field by collecting detailed information, which provide guiding opinions for finding the most influential journals and authors in NEPC-related fields. We hope to help researchers and readers in this field improve their understanding of NEPC research trends and provide ideas for future research from a unique perspective. Frontiers Media S.A. 2023-03-07 /pmc/articles/PMC10027713/ /pubmed/36959803 http://dx.doi.org/10.3389/fonc.2023.1146515 Text en Copyright © 2023 Gan, He, Li, Alsharafi, Zhou and Long https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Gan, Yu
He, Qiangrong
Li, Chao
Alsharafi, Bassam Lutf Mohammed
Zhou, Hengfeng
Long, Zhi
A bibliometric study of the top 100 most-cited papers in neuroendocrine prostate cancer
title A bibliometric study of the top 100 most-cited papers in neuroendocrine prostate cancer
title_full A bibliometric study of the top 100 most-cited papers in neuroendocrine prostate cancer
title_fullStr A bibliometric study of the top 100 most-cited papers in neuroendocrine prostate cancer
title_full_unstemmed A bibliometric study of the top 100 most-cited papers in neuroendocrine prostate cancer
title_short A bibliometric study of the top 100 most-cited papers in neuroendocrine prostate cancer
title_sort bibliometric study of the top 100 most-cited papers in neuroendocrine prostate cancer
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027713/
https://www.ncbi.nlm.nih.gov/pubmed/36959803
http://dx.doi.org/10.3389/fonc.2023.1146515
work_keys_str_mv AT ganyu abibliometricstudyofthetop100mostcitedpapersinneuroendocrineprostatecancer
AT heqiangrong abibliometricstudyofthetop100mostcitedpapersinneuroendocrineprostatecancer
AT lichao abibliometricstudyofthetop100mostcitedpapersinneuroendocrineprostatecancer
AT alsharafibassamlutfmohammed abibliometricstudyofthetop100mostcitedpapersinneuroendocrineprostatecancer
AT zhouhengfeng abibliometricstudyofthetop100mostcitedpapersinneuroendocrineprostatecancer
AT longzhi abibliometricstudyofthetop100mostcitedpapersinneuroendocrineprostatecancer
AT ganyu bibliometricstudyofthetop100mostcitedpapersinneuroendocrineprostatecancer
AT heqiangrong bibliometricstudyofthetop100mostcitedpapersinneuroendocrineprostatecancer
AT lichao bibliometricstudyofthetop100mostcitedpapersinneuroendocrineprostatecancer
AT alsharafibassamlutfmohammed bibliometricstudyofthetop100mostcitedpapersinneuroendocrineprostatecancer
AT zhouhengfeng bibliometricstudyofthetop100mostcitedpapersinneuroendocrineprostatecancer
AT longzhi bibliometricstudyofthetop100mostcitedpapersinneuroendocrineprostatecancer